Ocular Therapeutix Inc. (OCUL) at a glance
Ocular Therapeutix Inc. (OCUL) is a mid-cap Healthcare company. It trades at $10.36, with a 87.3% profit margin and revenue growth of 0.1%. It does not pay a dividend. Vestovix scores it 50/100 overall. Its strongest dimension is Value (65/100) and its weakest is Income (40/100). Its volatility is roughly in line with the market.
- Price
- $10.36
- Market cap
- $2.28B
- P/E ratio
- n/a
- Dividend yield
- None
- Beta
- 0.94
- 52-week range
- $6.23 to $16.44
Value
65
Growth
48
Income
40
Safety
50
Momentum
42
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,170.23-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$268.94+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$265.10-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$373.29-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$150.95-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.69+0.92%
2.16% yield
AMGN65
Amgen Inc.
$410.34-1.05%
2.76% yield